The PROCAINA (PROstate CAncer INdication Attitudes) Project (Part I): A survey among Italian radiation oncologists on postoperative radiotherapy in prostate cancer;Il progetto PROCAINA (PROstate CAncer INdication Attitudes) (Parte I): una survey tra gli oncologi radioterapisti italiani sulla radioterapia postoperatoria per il tumore prostatico

Radiologia Medica

Volumn 118, Issue 4, 2013, Pages 660-678

  Alongi, F ^a   De Bari, B ^b   Franco, P ^c   Ciammella, P ^d   Chekrine, T ^e   Livi, L ^f   Jereczek Fossa, B A ^g   Filippi, A R ^h  

^a HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^b Spedali Civili   (Italy)

^c Medical Physics Department   (Italy)

^d S MARIA NUOVA HOSPITAL   (Italy)

^e IBN ROCHD UNIVERSITY HOSPITAL   (Morocco)

^f UNIVERSITY OF FLORENCE   (Italy)

^g UNIVERSITY OF MILAN   (Italy)

^h UNIVERSITY OF TURIN   (Italy)

Author keywords

Postoperative radiotherapy; PROCAINA; Prostate cancer; Survey

Indexed keywords

AGED; ARTICLE; BIOPSY; CANCER STAGING; CLINICAL PRACTICE; DIAGNOSTIC IMAGING; HUMAN; ITALY; MALE; METHODOLOGY; MIDDLE AGED; ONCOLOGY; PATHOLOGY; PROSTATE TUMOR; QUESTIONNAIRE; SALVAGE THERAPY; STATISTICS;

AGED; BIOPSY; DIAGNOSTIC IMAGING; HUMANS; ITALY; MALE; MIDDLE AGED; NEOPLASM STAGING; PHYSICIAN'S PRACTICE PATTERNS; PROSTATIC NEOPLASMS; QUESTIONNAIRES; RADIATION ONCOLOGY; SALVAGE THERAPY;

EID: 84879421935     PISSN: 00338362     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11547-012-0913-8     Document Type: Article

References (44)

1. Thompson IM, Tangen CM, Paradelo J et al (2006) Adjuvant radiotherapy for pathologically advanced prostate cancer: a randomized clinical trial. JAMA 296:2329-2335 (Pubitemid 44749360)
2. Bolla M, van Poppel H, Collette L (2005) Postoperative radiotherapy after radical prostatectomy: a randomised controlledtrial (EORTC trial 22911). Lancet 366:572-578 (Pubitemid 41140332)
3. Wiegel T, Bottke D, Steiner U et al (2005) Phase III results of adjuvant radiotherapy (RT) versus "wait and see" in patients with pT3 prostate cancer following radical prostatectomy (RP), (ARO 96-02/AUO AP 09/95). J Clin Oncol 23:4513
4. Thompson IA, Tangen CM, Paradelo J et al (2009) Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term follow up of a randomized clinical trial. J Urol 181:956-962
5. Swanson P, Thompson IM (2007) Adjuvant radiotherapy for high risk patients following radical prostatectomy. Urol Oncol 25:515-519 (Pubitemid 350151906)
6. Swanson GP, Hussey MA, Tangen CM et al (2007) Predominant treatment failure in postprostatectomy patients is local: analysis of patterns of treatment failure in SWOG 8794. J Clin Oncol 25:2225-2229 (Pubitemid 46954647)
7. Van der Kwast TH, Bolla M, Van Poppel H et al (2007) Identification of patients with prostate cancer who benefit from immediate postoperative radiotherapy: EORTC 22911. J Clin Oncol 25:4178-4186 (Pubitemid 47548556)
8. Richaud P, Sargos P, Henriques de Figueiredo B et al (2010) Postoperative radiotherapy of prostate cancer. Cancer-Radiother 14:500-503
9. Staffurth J; Radiotherapy Development Board (2010) A review of the clinical evidence for intensity-modulated radiotherapy. Clin Oncol 22:643-657
10. Fogarty GB, Ng D, Liu G et al (2011) Volumetric modulated arc therapy is superior to conventional intensity modulated radiotherapy - a comparison among prostate cancer patients treated in an Australian centre. Radiat Oncol 6:108
11. Rong Y, Tang G, Welsh JS et al (2011) Helical tomotherapy versus single-arc intensity-modulated arc therapy: a collaborative dosimetric comparison between two institutions. Int J Radiat Oncol Biol Phys 81:284-296
12. Aznar MC, Petersen PM, Logadottir A et al (2010) Rotational radiotherapy for prostate cancer in clinical practice. Radiother Oncol 97:480-484
13. Davidson MT, Blake SJ, Batchelar DL et al (2011) Assessing the role of volumetric modulated arc therapy (VMAT) relative to IMRT and helical tomotherapy in the management of localized, locally advanced, and postoperative prostate cancer. Int J Radiat Oncol Biol Phys 80:1550-1558
14. Bossi A (2010) Which modality for prostate brachytherapy? Cancer Radiother 14:488-492
15. Pieters BR, de Back DZ, Koning CC, Zwinderman AH (2009) Comparison of three radiotherapy modalities on biochemical control and overall survival for the treatment of prostate cancer: a systematic review. Radiother Oncol 93:168-173
16. Pucar D, Sella T, Schöder H (2008) The role of imaging in the detection of prostate cancer local recurrence after radiation therapy and surgery. Curr Opin Urol 18:87-97 (Pubitemid 350307537)
17. Heidenreich A, Bellmunt J, Bolla M et al (2011) EAU Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Treatment of Clinically Localised Disease. European Urology 59: 61-71
18. Sullivan R, Peppercorn J, Sikora K et al (2011) Delivering affordable cancer care in high-income countries. Lancet Oncology 15:933-980
19. Valdagni R, Albers P, Bangma C et al (2011) The requirements of a specialist Prostate Cancer Unit: A discussion paper from the European School of Oncology. Eur J Cancer 47:1-7
20. Choo R, Hruby G, Hong J et al (2002) Inefficacy of salvage radiotherapy for rising PSA or clinically isolated local recurrence after radical prostatectomy. Int J Radiat Oncol Biol Phys 53:269-276 (Pubitemid 34522092)
21. Stephenson AJ, Shariat SF, Zelefsky MJ et al (2004) Salvage radiotherapy for recurrent prostate cancer after radical prostatectomy. JAMA 291:1325-1332 (Pubitemid 38541647)
22. Freedland SJ, Sutter ME, Dorey F, Aronson WJ (2003) Defining the ideal cutpoint for determining PSA recurrence after radical prostatectomy. Prostate-specific antigen. Urology 61:365-369 (Pubitemid 36206534)
23. Scattoni V, Montorsi F, Picchio M et al (2004) Diagnosis of local recurrence after radical prostatectomy. BJU Int 93:680-688 (Pubitemid 38375788)
24. Pelosi E, Arena V, Skanjeti A et al (2008) Role of whole-body 18F-choline PET/CT in disease detection in patients with biochemical relapse after radical treatment for prostate cancer. Radiol Med 113:895-904
25. Giovacchini G, Picchio M, Coradeschi E et al (2010) Predictive factors of [(11)C]choline PET/CT in patients with biochemical failure after radical prostatectomy. Eur J Nucl Med Mol Imaging 37:301-309
26. Beresford MJ, Gillatt D, Benson RJ, Ajithkumar T (2010) A systematic review of the role of imaging before salvage radiotherapy for postprostatectomy biochemical recurrence. Clin Oncology 22:46-55
27. Sella T, Schwartz LH, Swindle PW et al (2004) Suspected local recurrence after radical prostatectomy: endorectal coil MR imaging. Radiology 231:379-385 (Pubitemid 38552892)
28. Miralbell R, Vees H, Lozano J, Khan H et al (2007) Endorectal MRI assessment of local relapse after surgery for prostate cancer: a model to define treatment field guidelines for adjuvant radiotherapy in patients at high risk for local failure. Int J Radiat Oncol Biol Phys 67:356-361 (Pubitemid 46108320)
29. Michalski JM, Lawton C, El Naqa I et al (2010) Development of RTOG consensus guidelines for the definition of the clinical target volume for postoperative conformal radiation therapy for prostate cancer. Int J Radiat Oncol Biol Phys 76:361-368
30. Anscher MS (2004) Salvage radiotherapy for recurrent prostate cancer: the earlier the better. JAMA 291:1380-1382 (Pubitemid 38541653)
31. Kuban DA, Tucker SL, Dong L et al (2008) Long-term results of the M.D. Anderson randomized dose-escalation trial for prostate cancer. Int J Radiat Oncol Biol Phys 70:67-74 (Pubitemid 350251041)
32. Zelefsky MJ, Leibel SA, Gaudin PB (1998) Dose escalation with threedimensional conformal radiation therapy affects the outcome in prostate cancer. Int J Radiat Oncol Biol Phys 41:491-500 (Pubitemid 28275076)
33. Valicenti RK, Gomella LG, Ismail M et al (1998) Effect of higher radiation dose on biochemical control after radical prostatectomy for PT3N0 prostate cancer. Int J Radiat Oncol Biol Phys 42:501-506 (Pubitemid 28501097)
34. Valicenti RK, Gomella LG, Ismail M et al (1998) Durable efficacy of early postoperative radiation therapy for high-risk pT3N0 prostate cancer: the importance of radiation dose. Urology 52:1034-1040 (Pubitemid 28533373)
35. Cozzarini C, Fiorino C, Montorsi F et al (2009) The need for high radiation doses (≥70 Gy) in early post-operative irradiation after radical prostatectomy. A monoinstitutional analysis on 334 consecutive high risk patients. Int J Radiat Oncol Biol Phys 75:966-974
36. King CR, Kapp DS (2008) Radiotherapy after prostatectomy: is the evidence for dose escalation out there? Int J Radiat Oncol Biol Phys 71:346-350
37. Chapet O, De Bari B (2010) La radiothérapie hypofractionnée des cancers de prostate. Reflexions en medicine oncologique 36:17-21
38. Poortmans P, Bossi A, Vandeputte K et al (2007) Guidelines for target volume definition in post-operative radiotherapy for prostate cancer, on behalf of the EORTC Radiation Oncology Group. Radiat Oncol 84:121-127 (Pubitemid 47284534)
39. Bossi A (2007) Target volume for adjuvant radiotherapy after prostatectomy. Cancer Radiother 11:358-362 (Pubitemid 350102286)
40. Sidhom MA, Kneebone AB, Lehman M et al (2008) Post-prostatectomy radiation therapy: consensus guidelines of the Australian and New Zealand Radiation Oncology Genito-Urinary Group. Radiother Oncol 88:10-19
41. Fiorino C, Alongi F, Broggi S et al (2008) Physics aspects of prostate tomotherapy: planning optimization and image-guided issues. Acta Oncol 47:1309-1316
42. Alongi F, Fiorino C, Cozzarini C et al (2009) IMRT significantly reduces acute toxicity of wholepelvis irradiation in patients treated with post-operative adjuvant or salvage radiotherapy after radical prostatectomy. Radiother Oncol 93:207-212
43. Cozzarini C, Fiorino C, Di Muzio N et al (2007) Significant reduction of acute toxicity following pelvic irradiation with helical tomotherapy in patients with localized prostate cancer. Radiother Oncol 84:164-170 (Pubitemid 47299141)
44. Alongi F, Di Muzio N (2009) Imageguided radiation therapy: a new era for the radiation oncologist? Int J Clin Oncol 14:568-569